167 related articles for article (PubMed ID: 27163969)
1. LC-MS/MS as a tool for TDM services: Where are we?
Shipkova M; Svinarov D
Clin Biochem; 2016 Sep; 49(13-14):1009-23. PubMed ID: 27163969
[No Abstract] [Full Text] [Related]
2. Therapeutic drug monitoring and LC-MS/MS.
Adaway JE; Keevil BG
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():33-49. PubMed ID: 21992751
[TBL] [Abstract][Full Text] [Related]
3. Advances in antifungal drug measurement by liquid chromatography-mass spectrometry.
Zheng YZ; Wang S
Clin Chim Acta; 2019 Apr; 491():132-145. PubMed ID: 30685359
[TBL] [Abstract][Full Text] [Related]
4. [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].
Saint-Marcoux F
Ann Biol Clin (Paris); 2015; 73(1):49-53. PubMed ID: 25582722
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant.
Aucella F; Lauriola V; Vecchione G; Tiscia GL; Grandone E
J Pharm Biomed Anal; 2013 Dec; 86():123-6. PubMed ID: 23995754
[TBL] [Abstract][Full Text] [Related]
7. Bioanalytical LC-MS/MS validation of therapeutic drug monitoring assays in oncology.
van Nuland M; Rosing H; Schellens JHM; Beijnen JH
Biomed Chromatogr; 2020 Jan; 34(1):e4623. PubMed ID: 31215049
[TBL] [Abstract][Full Text] [Related]
8. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.
Ghareeb M; Akhlaghi F
Bioanalysis; 2015; 7(8):1037-58. PubMed ID: 25966013
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring by LC-MS-MS with special focus on anti-infective drugs.
Müller DM; Rentsch KM
Anal Bioanal Chem; 2010 Nov; 398(6):2573-94. PubMed ID: 20652551
[TBL] [Abstract][Full Text] [Related]
10. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.
Pohanka A; Rosenborg S; Lindh JD; Beck O
Clin Biochem; 2016 Sep; 49(13-14):1024-31. PubMed ID: 27372284
[TBL] [Abstract][Full Text] [Related]
11. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
Garg U; Zhang YV
Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
[TBL] [Abstract][Full Text] [Related]
12. LC-MS application for therapeutic drug monitoring in alternative matrices.
Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A
J Pharm Biomed Anal; 2019 Mar; 166():40-51. PubMed ID: 30609393
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS for immunosuppressant therapeutic drug monitoring.
Sallustio BC
Bioanalysis; 2010 Jun; 2(6):1141-53. PubMed ID: 21083213
[TBL] [Abstract][Full Text] [Related]
14. Quantification of micafungin in human plasma by liquid chromatography-tandem mass spectrometry.
Cangemi G; Barco S; Bandettini R; Castagnola E
Anal Bioanal Chem; 2014 Feb; 406(6):1795-8. PubMed ID: 24408301
[TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update.
Briki M; Murisier A; Guidi M; Seydoux C; Buclin T; Marzolini C; Girardin FR; Thoma Y; Carrara S; Choong E; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1236():124039. PubMed ID: 38490042
[TBL] [Abstract][Full Text] [Related]
17. A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS.
Linder C; Andersson M; Wide K; Beck O; Pohanka A
Bioanalysis; 2015; 7(16):2031-9. PubMed ID: 26327183
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.
Patteet L; Maudens KE; Vermeulen Z; Dockx G; De Doncker M; Morrens M; Sabbe B; Neels H
Clin Biochem; 2014 Dec; 47(18):336-9. PubMed ID: 25289972
[TBL] [Abstract][Full Text] [Related]
20. Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice.
Yoon SJ; Lee K; Oh J; Woo HI; Lee SY
Clin Biochem; 2019 Aug; 70():14-17. PubMed ID: 31175859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
